.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Accenture
Argus Health
UBS
Cantor Fitzgerald
QuintilesIMS
Medtronic
Chubb
Chinese Patent Office
Healthtrust

Most prolific drug patent challengers

This chart shows the generic pharmaceutical companies that had the most successful drug patent challenges from 2012 to 2017.

Companies that successfully challenge patents on branded drugs are granted six months of generic exclusivity. Because first-on-market generics tend to sell at 70% or more of the price of the branded drug, the financial rewards stemming from the market exclusivity granted for drug patent challenges can more than cover the subtantial costs of drug patent challenge and associated litigation.

The most successful patent challengers from 2012 to 2017 were

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the database preview and plans and pricing

botpot